FDA-Cleared Innovation for Personalized Surgery
Smith+Nephew (NYSE: SNN) has received FDA clearance for Coriograph, its pre-operative planning and modeling service, specifically for total hip arthroplasty (THA) procedures using the Cori surgical robotic system.
Enhanced Pre-Operative Planning
Coriograph leverages X-rays or CT scans to create patient-specific surgical plans, enabling surgeons to optimize implant positioning and component sizing. This new tool aims to deliver better patient outcomes by personalizing surgical care.
Dr. George Haidukewych of Orlando Health Jewett Orthopedic Institute recently performed the first procedure using Coriograph, calling it “invaluable in saving time and optimizing outcomes.”
Expanding Cori’s Capabilities
Coriograph extends the functionality of the Cori system, a versatile robotic platform for hip and knee arthroplasty. Key features include:
- Advanced modeling: Personalizes care using 3D simulations tailored to patient anatomy.
- Image-agnostic planning: Works seamlessly with both X-rays and CT scans.
A Personal Perspective
Craig Gaffin, president of Global Orthopaedics at Smith+Nephew, shared his personal experience:
“My hip was the first to be planned using Coriograph services. This technology provided insights into my post-surgery activity expectations, personalized to my anatomy.”
Driving Personalized Orthopedic Care
With Coriograph’s integration, Smith+Nephew is advancing the field of orthopedics by offering customizable, patient-specific solutions for hip and knee replacements, aiming to set new standards in precision and outcomes.
Follow MEDWIRE.AI for updates on innovative surgical technologies transforming orthopedic care.
